Intravenously usable fully serotype 3 oncolytic adenovirus coding for CD40L as an enabler of dendritic cell therapy

Year of publication

2017

Authors

Zafar, Sadia; Parviainen, Suvi; Siurala, Mikko; Hemminki, Otto; Havunen, Riikka; Tahtinen, Siri; Bramante, Simona; Vassilev, Lotta; Wang, Hongjie; Lieber, Andre; Hemmi, Silvio; de Gruijl, Tanja; Kanerva, Anna; Hemminki, Akseli

Organizations and authors

University of Helsinki

Hemminki Akseli

Kanerva Anna

Siurala Mikko

Hemminki Otto

Havunen Riikka

Bramante Simona

Tahtinen Siri

Parviainen Suvi

Helsinki University Hospital

Hemminki Akseli

Kanerva Anna

Siurala Mikko

Hemminki Otto

Havunen Riikka

Bramante Simona

Tahtinen Siri

Parviainen Suvi

Publication type

Publication format

Article

Parent publication type

Journal

Article type

Original article

Audience

Scientific

Peer-reviewed

Peer-Reviewed

MINEDU's publication type classification code

A1 Journal article (refereed), original research

Publication channel information

Journal/Series

Oncoimmunology

Parent publication name

OncoImmunology

Volume

Issue

Article number

1265717

ISSN

2162-402X

Publication forum

76361

Publication forum level

Open access

Open access in the publisher’s service

Yes

Open access of publication channel

Fully open publication channel

Self-archived

Yes

Other information

Fields of science

Biomedicine; Cancers

Keywords

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Publication country

United States

Internationality of the publisher

International

Language

English

International co-publication

Yes

Co-publication with a company

Yes

DOI

10.1080/2162402X.2016.1265717

The publication is included in the Ministry of Education and Culture’s Publication data collection

Yes